整合素阻断剂类药物的研究与开发进展(5)
第1页 |
参见附件。
[11] Moruno MC,Rechenmacher F,Kessler H. Cilengitide:the first anti-angiogenic small molecule drug candidate design,synthesis and clinical evaluation[J]. Anticancer Agents Med Chem,2010,10(10):753-768.
[12] 范鸣. 抗α5β1整合素单克隆抗体类抗癌药Volociximab[J]. 药学进展,2011,35(4):186-188.
[13] Cianfrocca ME,Kimmel KA,Gallo J,et al. Phase 1 trial of the antiangiogenic peptide ATN-161(Ac-PHSCN-NH2),a beta integrin antagonist,in patients with solid tumours[J]. British Journal of Cancer,2006,94(11):1621-1626 ......
您现在查看是摘要介绍页,详见PDF附件。